Cargando…

Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis

Etanercept is a monoclonal antibody targeted against Tumour Necrosis Factor-alpha (TNF-a) which is an effective treatment for rheumatoid arthritis and is in cases where conventional disease modifying agents such as methotrexate have failed. Neurological complications of treatment have been documente...

Descripción completa

Detalles Bibliográficos
Autores principales: Defty, Helen, Sames, Edward, Doherty, Teresa, Hughes, Rodney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615585/
https://www.ncbi.nlm.nih.gov/pubmed/23573450
http://dx.doi.org/10.1155/2013/728371
Descripción
Sumario:Etanercept is a monoclonal antibody targeted against Tumour Necrosis Factor-alpha (TNF-a) which is an effective treatment for rheumatoid arthritis and is in cases where conventional disease modifying agents such as methotrexate have failed. Neurological complications of treatment have been documented. We describe a case of transverse myelitis occurring in a 48 year-old lady with RA since 1994 who had been receiving etanercept for four years.